Leuprolide Recruiting Phase 2 Trials for Myelodysplastic Syndrome / Multiple Myeloma (MM) / Non-Hodgkin's Lymphoma (NHL) / Leukemias Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01746849Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation